Compare PCOR & FMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PCOR | FMS |
|---|---|---|
| Founded | 2003 | 1996 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Misc Health and Biotechnology Services |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.3B | 14.1B |
| IPO Year | 2021 | 1996 |
| Metric | PCOR | FMS |
|---|---|---|
| Price | $77.53 | $23.28 |
| Analyst Decision | Buy | Sell |
| Analyst Count | 18 | 2 |
| Target Price | ★ $83.06 | $30.00 |
| AVG Volume (30 Days) | ★ 1.3M | 482.1K |
| Earning Date | 11-05-2025 | 11-04-2025 |
| Dividend Yield | N/A | ★ 2.45% |
| EPS Growth | N/A | ★ 8.62 |
| EPS | N/A | ★ 2.86 |
| Revenue | $1,275,450,000.00 | ★ $23,046,819,198.00 |
| Revenue This Year | $16.35 | $2.12 |
| Revenue Next Year | $12.09 | $2.92 |
| P/E Ratio | ★ N/A | $15.86 |
| Revenue Growth | ★ 14.94 | 2.10 |
| 52 Week Low | $53.71 | $22.05 |
| 52 Week High | $88.92 | $30.46 |
| Indicator | PCOR | FMS |
|---|---|---|
| Relative Strength Index (RSI) | 60.44 | 37.10 |
| Support Level | $74.36 | $22.51 |
| Resistance Level | $76.70 | $24.20 |
| Average True Range (ATR) | 2.51 | 0.30 |
| MACD | 0.37 | 0.09 |
| Stochastic Oscillator | 92.58 | 45.27 |
Procore Technologies Inc is a cloud-based construction management software company. It generates revenue through subscriptions for access to its software products. The company's products include Design Coordination, BIM, Field Productivity, Project Financials, Invoice Management, Portfolio Financials, Capital Planning, Accounting Integrations, and Analytics. The software products are hosted on its cloud-based SaaS construction management platform. Subscriptions are sold for a fixed fee and revenue is recognized ratably over the term of the subscription.
Fresenius Medical Care is the largest dialysis company in the world, treating about 300,000 patients from nearly 3,700 clinics worldwide as of December 2024. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.